First Year Implementation and Performance of the Republic of Korea’s National Antimicrobial Stewardship Program Pilot: Policy Directions for Sustainable Expansion
- 1Division of Antimicrobial Resistance Control, Department of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency Cheongju Korea
Abstract
Objectives: This report analyzes the implementation and performance of the first year of the Republic of Korea’s National Antimicrobial Stewardship Program (ASP) pilot and proposes policy directions for its sustainable operation and a phased expansion.
Methods: We examined implementation data from 78 participating general and tertiary hospitals with having more than 300 beds from November 1, 2024, to December 31, 2025. Data collected through and annual reports, program guidelines, annual evaluations, and on-site inspection were reviewed to assess ASP infrastructure and major structural and process indicators.
Results: In all, 78 (45.9%) of 170 eligible institutions participated. These institutions created multidisciplinary ASP teams that included 695 personnel and developed 622 institution-specific antibiotic use guidelines. These personnel implemented an average of 5.7 of 7 prescribing intervention activities, with a mean acceptance rate of 81.7%. Restricted antibiotics that included 68 active ingredients were managed, with a mean institutional approval rate of 89.5%. Information systems that supported ASP activities were operated in 73 institutions (93.6%). All of the institutions met the basic evaluation criteria, and 64 (82.1%) received an A or B grade. The total financial support in the first year was KRW 65.97 billion.
Conclusions: The first-year pilot established the ASP workforce, operational systems, and implementation infrastructure through national financial support and evaluation, exhibiting a high level of implementation. However, short-term changes in antibiotic use and antimicrobial resistance were difficult to assess. Longitudinal evaluation, tailored support reflecting workforce and infrastructure gaps, and the gradual transition to outcome-oriented evaluation are needed to support expansion to general hospitals and hospital-level institutions.
Related
- Implementation of an antimicrobial stewardship program in a multicenter neonatal intensive care unit collaborative: a mixed-methods staff resource needs evaluation
- Implementation of antimicrobial stewardship programmes in hospitals of the Brazilian public health system: PeGASUS study protocol
- Diagnosing antimicrobial stewardship needs in a pluralistic health system in India: Why Local Evidence Must Guide Implementation
- Systematic review of sustainable AI implementation in medical imaging: Challenges, strategies, and future directions
- Restrictive vs. liberal blood transfusion strategies in Africa: clinical outcomes, resource stewardship, and future directions
BibTeX
@article{jeong2026first,
title = {{First Year Implementation and Performance of the Republic of Korea’s National Antimicrobial Stewardship Program Pilot: Policy Directions for Sustainable Expansion}},
author = {Young-Il Jeong and Yeo Won Jin and In Kyoung Kim and U Jin Cho and Eun Young Choi and Na-Ri Shin},
journal = {Public Health Weekly Report},
year = {2026},
month = nov,
doi = {10.56786/phwr.2026.19.43.2},
url = {https://doi.org/10.56786/phwr.2026.19.43.2},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - First Year Implementation and Performance of the Republic of Korea’s National Antimicrobial Stewardship Program Pilot: Policy Directions for Sustainable Expansion
AU - Young-Il Jeong
AU - Yeo Won Jin
AU - In Kyoung Kim
AU - U Jin Cho
AU - Eun Young Choi
AU - Na-Ri Shin
PY - 2026
DA - 2026/11/12
JO - Public Health Weekly Report
DO - 10.56786/phwr.2026.19.43.2
UR - https://doi.org/10.56786/phwr.2026.19.43.2
AB - Objectives: This report analyzes the implementation and performance of the first year of the Republic of Korea’s National Antimicrobial Stewardship Program (ASP) pilot and proposes policy directions for its sustainable operation and a phased expansion. Methods: We examined implementation data from 78 participating general and tertiary hospitals with having more than 300 beds from November 1, 2024, to December 31, 2025. Data collected through and annual reports, program guidelines, annual evaluations, and on-site inspection were reviewed to assess ASP infrastructure and major structural and process indicators. Results: In all, 78 (45.9%) of 170 eligible institutions participated. These institutions created multidisciplinary ASP teams that included 695 personnel and developed 622 institution-specific antibiotic use guidelines. These personnel implemented an average of 5.7 of 7 prescribing intervention activities, with a mean acceptance rate of 81.7%. Restricted antibiotics that included 68 active ingredients were managed, with a mean institutional approval rate of 89.5%. Information systems that supported ASP activities were operated in 73 institutions (93.6%). All of the institutions met the basic evaluation criteria, and 64 (82.1%) received an A or B grade. The total financial support in the first year was KRW 65.97 billion. Conclusions: The first-year pilot established the ASP workforce, operational systems, and implementation infrastructure through national financial support and evaluation, exhibiting a high level of implementation. However, short-term changes in antibiotic use and antimicrobial resistance were difficult to assess. Longitudinal evaluation, tailored support reflecting workforce and infrastructure gaps, and the gradual transition to outcome-oriented evaluation are needed to support expansion to general hospitals and hospital-level institutions.
SN - 3092-491X
ER -